Health related quality of life among Rheumatic Fever and Rheumatic Heart Disease patients in India.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
03
08
2020
accepted:
19
10
2021
entrez:
29
10
2021
pubmed:
30
10
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Measurement of health-related quality of life (HRQOL) of people with chronic illnesses has become extremely important as the mortality rates associated with such illnesses have decreased and survival rates have increased. Thereby, such measurements not only provide insights into physical, mental and social dimensions of patient's health, but also allow monitoring of the results of interventions, complementing the traditional methods based on morbidity and mortality. The present study was conducted to describe the HRQOL of patients suffering from Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD), and to identify socio-demographic and clinical factors as predictors of HRQOL. A cross-sectional study was conducted to assess the HRQOL among 702 RF and RHD patients using EuroQol 5-dimensions 5-levels instrument (EQ-5D-5L), EuroQol Visual Analogue Scale and Time Trade off method. Mean EQ-5D-5L quality of life scores were calculated using EQ5D index value calculator across different stages of RF and RHD. Proportions of patients reporting problems in different attributes of EQ-5D-5L were calculated. The impact of socio-economic determinants on HRQOL was assessed. The mean EQ-5D-5L utility scores among RF, RHD and RHD with Congestive heart failure patients (CHF) were estimated as 0.952 [95% Confidence Interval (CI): 0.929-0.975], 0.820 [95% CI: 0.799-0.842] and 0.800 [95% CI: 0.772-0.829] respectively. The most frequently reported problem among RF/RHD patients was pain/discomfort (33.8%) followed by difficulty in performing usual activities (23.9%) patients, mobility (22.7%) and anxiety/depression (22%). Patients with an annual income of less than 50,000 Indian National Rupees (INR) reported the highest EQ-5D-5L score of 0.872, followed by those in the income group of more than INR 200,000 (0.835), INR 50,000-100,000 (0.832) and INR 100,000-200,000 (0.828). Better HRQOL was reported by RHD patients (including RHD with CHF) who underwent balloon valvotomy (0.806) as compared to valve replacement surgery (0.645). RF and RHD significantly impact the HRQOL of patients. Interventions aiming to improve HRQOL of RF/RHD patients should focus upon ameliorating pain and implementation of secondary prevention strategies for reducing the progression from ARF to RHD and prevention of RHD-related complications.
Sections du résumé
BACKGROUND
Measurement of health-related quality of life (HRQOL) of people with chronic illnesses has become extremely important as the mortality rates associated with such illnesses have decreased and survival rates have increased. Thereby, such measurements not only provide insights into physical, mental and social dimensions of patient's health, but also allow monitoring of the results of interventions, complementing the traditional methods based on morbidity and mortality.
OBJECTIVE
The present study was conducted to describe the HRQOL of patients suffering from Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD), and to identify socio-demographic and clinical factors as predictors of HRQOL.
METHODOLOGY
A cross-sectional study was conducted to assess the HRQOL among 702 RF and RHD patients using EuroQol 5-dimensions 5-levels instrument (EQ-5D-5L), EuroQol Visual Analogue Scale and Time Trade off method. Mean EQ-5D-5L quality of life scores were calculated using EQ5D index value calculator across different stages of RF and RHD. Proportions of patients reporting problems in different attributes of EQ-5D-5L were calculated. The impact of socio-economic determinants on HRQOL was assessed.
RESULTS
The mean EQ-5D-5L utility scores among RF, RHD and RHD with Congestive heart failure patients (CHF) were estimated as 0.952 [95% Confidence Interval (CI): 0.929-0.975], 0.820 [95% CI: 0.799-0.842] and 0.800 [95% CI: 0.772-0.829] respectively. The most frequently reported problem among RF/RHD patients was pain/discomfort (33.8%) followed by difficulty in performing usual activities (23.9%) patients, mobility (22.7%) and anxiety/depression (22%). Patients with an annual income of less than 50,000 Indian National Rupees (INR) reported the highest EQ-5D-5L score of 0.872, followed by those in the income group of more than INR 200,000 (0.835), INR 50,000-100,000 (0.832) and INR 100,000-200,000 (0.828). Better HRQOL was reported by RHD patients (including RHD with CHF) who underwent balloon valvotomy (0.806) as compared to valve replacement surgery (0.645).
CONCLUSION
RF and RHD significantly impact the HRQOL of patients. Interventions aiming to improve HRQOL of RF/RHD patients should focus upon ameliorating pain and implementation of secondary prevention strategies for reducing the progression from ARF to RHD and prevention of RHD-related complications.
Identifiants
pubmed: 34714892
doi: 10.1371/journal.pone.0259340
pii: PONE-D-20-24114
pmc: PMC8555809
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0259340Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Asia Pac J Public Health. 2015 Mar;27(2):NP1013-25
pubmed: 24097919
Heart. 2005 Sep;91(9):1193-8
pubmed: 16103557
Ann Rheum Dis. 2000 Nov;59(11):892-7
pubmed: 11053068
Value Health. 2009 Nov-Dec;12(8):1194-200
pubmed: 19695009
Ann Med. 2001 Jul;33(5):337-43
pubmed: 11491192
Value Health. 2007 Jan-Feb;10(1):73-81
pubmed: 17261118
Value Health. 2008 Jul-Aug;11(4):742-64
pubmed: 18179668
N Engl J Med. 1996 Mar 28;334(13):835-40
pubmed: 8596551
Pediatrics. 2000 May;105(5):1082-9
pubmed: 10790466
Circulation. 2000 Nov 7;102(19 Suppl 3):III136-41
pubmed: 11082376
Med Decis Making. 1984;4(3):315-29
pubmed: 6335216
N Engl J Med. 2017 Aug 24;377(8):713-722
pubmed: 28834488
Circulation. 2015 May 19;131(20):1806-18
pubmed: 25908771
Health Technol Assess. 2014 Feb;18(9):1-224
pubmed: 24524660
Pharmacoecon Open. 2018 Mar;2(1):1-3
pubmed: 29464668
Chin J Cancer. 2014 Jul;33(7):339-45
pubmed: 24698497
BMC Med Res Methodol. 2004 Apr 29;4:10
pubmed: 15117417
Pediatr Cardiol. 2007 Jul-Aug;28(4):255-62
pubmed: 17486393
Pediatr Cardiol. 1999 Jan-Feb;20(1):57-9; discussion 60
pubmed: 9861079
Br Med Bull. 2010;96:5-21
pubmed: 21037243
Eur J Health Econ. 2013 Jul;14 Suppl 1:S1-3
pubmed: 23900659
Pediatrics. 2003 Jul;112(1 Pt 1):24-8
pubmed: 12837863
J Chronic Dis. 1987;40(6):593-603
pubmed: 3298297
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
J Cardiovasc Dis Res. 2013 Mar;4(1):25-9
pubmed: 24023467
Eur J Pediatr. 2010 Mar;169(3):333-47
pubmed: 19768468
Glob Heart. 2020 Sep 14;15(1):62
pubmed: 33150127
Heart. 2002 Apr;87(4):356-62
pubmed: 11907011
J Egypt Public Health Assoc. 2010;85(3-4):205-22
pubmed: 21244818
Health Qual Life Outcomes. 2008 Nov 03;6:91
pubmed: 18980676
Health Qual Life Outcomes. 2011 Nov 28;9:106
pubmed: 22123196
Pediatrics. 2008 May;121(5):e1060-7
pubmed: 18450848
Health Qual Life Outcomes. 2013 Nov 15;11:198
pubmed: 24284003
J Health Econ. 2002 Mar;21(2):271-92
pubmed: 11939242
J Pak Med Assoc. 2018 Mar;68(3):370-375
pubmed: 29540870
J Clin Epidemiol. 2002 Jan;55(1):67-76
pubmed: 11781124
F1000Res. 2018 Feb 28;7:245
pubmed: 29770210
J Natl Cancer Inst. 2004 Apr 21;96(8):604-15
pubmed: 15100338
Health Qual Life Outcomes. 2003 Oct 16;1:54
pubmed: 14613568
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;:145-56
pubmed: 15818371
Qual Life Res. 2010 Oct;19(8):1145-54
pubmed: 20496167
Int J Psychiatry Med. 1983-1984;13(4):327-43
pubmed: 6671863